Industry
Chemicals - Specialty
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Loading...
Open
23.06
Mkt cap
16B
Volume
1.9M
High
23.14
P/E Ratio
51.13
52-wk high
28.00
Low
22.83
Div yield
N/A
52-wk low
18.08
Portfolio Pulse from Benzinga Newsdesk
December 07, 2023 | 2:28 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2023 | 2:18 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2023 | 1:20 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2023 | 8:46 am
Portfolio Pulse from Benzinga Newsdesk
October 27, 2023 | 3:06 pm
Portfolio Pulse from Benzinga Newsdesk
October 27, 2023 | 10:08 am
Portfolio Pulse from Benzinga Insights
October 26, 2023 | 4:01 pm
Portfolio Pulse from Charles Gross
September 29, 2023 | 2:05 pm
Portfolio Pulse from Benzinga Newsdesk
September 29, 2023 | 10:00 am
Portfolio Pulse from Benzinga Insights
September 28, 2023 | 3:01 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.